0
Your cart

Your cart is empty

Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries

Buy Now

The Politics of the International Pricing of Prescription Drugs (Hardcover, New) Loot Price: R2,499
Discovery Miles 24 990
The Politics of the International Pricing of Prescription Drugs (Hardcover, New): Christophe S Harrison

The Politics of the International Pricing of Prescription Drugs (Hardcover, New)

Christophe S Harrison

 (sign in to rate)
Loot Price R2,499 Discovery Miles 24 990 | Repayment Terms: R234 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Harrison analyzes how the U.S. research pharmaceutical industry, faced with domestic political opposition to the prices it charged for prescription drugs, chose to pursue its policy goal of greater appropriability of its intellectual property through the institutions of foreign economic policymaking. As Harrison explains, a new body of literature has developed to analyze the emergence of intellectual property as a major international trade issue. For many researchers, the inclusion of trade related intellectual property (TRIPS) into the Uruguay round of the General Agreement on Tariffs and trade (GATT) negotiations marks an important demonstration of the political influence of U.S. knowledge-intensive industries. However, as he demonstrates, a more thorough specification of the domestic political environment reveals that the research pharmaceutical industry was incapable of achieving its domestic policy objectives at the same time that it is credited with immense international political power. By providing a theory of institutional choice, Harrison reconciles this incongruity. He explains the strategic choices of the research pharmaceutical industry as a function of the transaction costs associated with pursuing its policy objectives within a variety of institutional alternatives. He concludes that he internationalization of intellectual property rights was a result of the changing domestic political environment in which the research pharmaceutical industry found itself the loser in a series of domestic economic policy battles. A thoughtful analysis of particular important to scholars, researchers, and policy makers involved with international trade, intellectual property, the pharmaceutical industry, and public policy.

General

Imprint: Praeger Publishers Inc
Country of origin: United States
Release date: March 2004
First published: March 2004
Authors: Christophe S Harrison
Dimensions: 234 x 156 x 14mm (L x W x T)
Format: Hardcover
Pages: 224
Edition: New
ISBN-13: 978-0-275-98010-8
Categories: Books > Business & Economics > Economics > Political economy
Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries
Promotions
LSN: 0-275-98010-3
Barcode: 9780275980108

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners